Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

1.

Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.

Rother A, Glander P, Vitt E, Czock D, von Ahsen N, Armstrong VW, Oellerich M, Budde K, Feneberg R, Tönshoff B, Weber LT.

Eur J Clin Pharmacol. 2012 Jun;68(6):913-22. doi: 10.1007/s00228-011-1203-4. Epub 2012 Jan 25.

PMID:
22274404
2.

Proteomics approach to identify the interacting partners of cellular prion protein and characterization of Rab7a interaction in neuronal cells.

Zafar S, von Ahsen N, Oellerich M, Zerr I, Schulz-Schaeffer WJ, Armstrong VW, Asif AR.

J Proteome Res. 2011 Jul 1;10(7):3123-35. doi: 10.1021/pr2001989. Epub 2011 Jun 7.

PMID:
21604690
3.

Lipid-apheresis improves microcirculation of the upper limbs.

Rossenbach J, Mueller GA, Lange K, Armstrong VW, Schmitto JD, Hintze E, Helfmann J, Konstantinides S, Koziolek MJ.

J Clin Apher. 2011;26(4):167-73. doi: 10.1002/jca.20285. Epub 2011 Apr 15.

PMID:
21500250
4.

How delayed graft function impacts exposure to mycophenolic acid in patients after renal transplantation.

van Gelder T, Silva HT, de Fijter H, Budde K, Kuypers D, Mamelok RD, Armstrong VW, Oellerich M.

Ther Drug Monit. 2011 Apr;33(2):155-64. doi: 10.1097/FTD.0b013e31820c0a96.

PMID:
21383657
5.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I.

J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527.

PMID:
21157024
6.

Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.

Prémaud A, Weber LT, Tönshoff B, Armstrong VW, Oellerich M, Urien S, Marquet P, Rousseau A.

Pharmacol Res. 2011 Mar;63(3):216-24. doi: 10.1016/j.phrs.2010.10.017. Epub 2010 Nov 5.

PMID:
21056671
7.

Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.

Petrova DT, Brandhorst G, Brehmer F, Gross O, Oellerich M, Armstrong VW.

Ther Drug Monit. 2010 Aug;32(4):405-12. doi: 10.1097/FTD.0b013e3181e44260.

PMID:
20592645
8.

Differential proteome and phosphoproteome signatures in human T-lymphoblast cells induced by sirolimus.

Schultze FC, Petrova DT, Oellerich M, Armstrong VW, Asif AR.

Cell Prolif. 2010 Aug;43(4):396-404. doi: 10.1111/j.1365-2184.2010.00690.x.

PMID:
20590665
9.

Retrospective analysis of long-term lipid apheresis at a single center.

Koziolek MJ, Hennig U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Müller GA.

Ther Apher Dial. 2010 Apr;14(2):143-52. doi: 10.1111/j.1744-9987.2009.00747.x.

PMID:
20438535
10.

Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.

Bramlage CP, Armstrong VW, Zapf A, Bramlage P, Mueller GA, Koziolek MJ.

Ther Apher Dial. 2010 Apr;14(2):136-42. doi: 10.1111/j.1744-9987.2009.00715.x.

PMID:
20438534
11.

Mycophenolic acid predose concentrations and renal function in a mouse model for progressive renal fibrosis.

Brandhorst G, Brehmer F, Petrova DT, Gross O, Miosge N, Armstrong VW, Oellerich M.

Ther Drug Monit. 2010 Feb;32(1):73-8. doi: 10.1097/FTD.0b013e3181c91fc4.

PMID:
20042922
12.

Thirty years of Therapeutic Drug Monitoring.

Armstrong VW.

Ther Drug Monit. 2009 Dec;31(6):669. doi: 10.1097/FTD.0b013e3181c73b3a. No abstract available.

PMID:
19935360
13.

The acyl glucuronide metabolite of mycophenolic acid induces tubulin polymerization in vitro.

Feichtiger H, Wieland E, Armstrong VW, Shipkova M.

Clin Biochem. 2010 Jan;43(1-2):208-13. doi: 10.1016/j.clinbiochem.2009.08.023. Epub 2009 Sep 8.

PMID:
19744471
14.

Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.

Nyirenda MJ, Carter R, Tang JI, de Vries A, Schlumbohm C, Hillier SG, Streit F, Oellerich M, Armstrong VW, Fuchs E, Seckl JR.

Diabetes. 2009 Dec;58(12):2873-9. doi: 10.2337/db09-0873. Epub 2009 Aug 31.

15.

Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.

Braun F, Schöcklmann H, Ziegler E, Kunzendorf U, Armstrong VW, Renders L.

Clin Pharmacol Ther. 2009 Oct;86(4):411-5. doi: 10.1038/clpt.2009.129. Epub 2009 Jul 15.

PMID:
19606088
16.

T-786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis.

Asif AR, Oellerich M, Armstrong VW, Hecker M, Cattaruzza M.

J Proteome Res. 2009 Jun;8(6):3161-8. doi: 10.1021/pr800998k.

PMID:
19320461
17.

Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.

Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M.

Ther Drug Monit. 2009 Apr;31(2):205-10. doi: 10.1097/FTD.0b013e31819743d9.

PMID:
19307937
18.

Differential proteomic analysis of lymphocytes treated with mycophenolic acid reveals caspase 3-induced cleavage of rho GDP dissociation inhibitor 2.

Heller T, Asif AR, Petrova DT, Doncheva Y, Wieland E, Oellerich M, Shipkova M, Armstrong VW.

Ther Drug Monit. 2009 Apr;31(2):211-7. doi: 10.1097/FTD.0b013e318196fb73.

PMID:
19214148
19.

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.

Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M.

Ther Drug Monit. 2009 Apr;31(2):139-52. doi: 10.1097/FTD.0b013e318198d092.

PMID:
19177031
20.

Regulation of IL2 and NUCB1 in mononuclear cells treated with acyl glucuronide of mycophenolic acid reveals effects independent of inosine monophosphate dehydrogenase inhibition.

Petrova DT, Heller T, Hitt R, Wieland E, Oellerich M, Armstrong VW, Shipkova M.

Ther Drug Monit. 2009 Feb;31(1):31-41. doi: 10.1097/FTD.0b013e318192693e.

PMID:
19065122
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk